Pharvaris (PHVS)
(Delayed Data from NSDQ)
$19.08 USD
-0.43 (-2.20%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $19.22 +0.14 (0.73%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Balance Sheet
Fiscal Year End for Pharvaris NV falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 423 | 171 | 248 | 113 | -99,999 |
Receivables | 1 | 0 | 1 | 1 | NA |
Notes Receivable | 0 | 0 | 0 | 0 | NA |
Inventories | 0 | 0 | 0 | 0 | NA |
Other Current Assets | 6 | 5 | 2 | 2 | NA |
Total Current Assets | 431 | 176 | 251 | 115 | NA |
Net Property & Equipment | 0 | 0 | 0 | 0 | NA |
Investments & Advances | 0 | 0 | 0 | 0 | NA |
Other Non-Current Assets | 0 | 0 | 0 | 0 | NA |
Deferred Charges | 0 | 0 | 0 | 0 | NA |
Intangibles | 0 | 0 | 0 | 0 | NA |
Deposits & Other Assets | 0 | 0 | 0 | 0 | NA |
Total Assets | 432 | 177 | 251 | 115 | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | NA |
Accounts Payable | 3 | 7 | 3 | 1 | NA |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | NA |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | NA |
Accrued Expenses | 12 | 11 | 5 | 5 | NA |
Income Taxes Payable | 0 | 0 | 0 | 0 | NA |
Other Current Liabilities | 0 | 0 | 0 | 0 | NA |
Total Current Liabilities | 16 | 19 | 8 | 6 | NA |
Mortgages | 0 | 0 | 0 | 0 | NA |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | NA |
Convertible Debt | 0 | 0 | 0 | 0 | NA |
Long-Term Debt | 0 | 0 | 0 | 0 | NA |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | NA |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | NA |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | NA |
Total Liabilities | 16 | 19 | 8 | 6 | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | NA |
Common Stock (Par) | 7 | 4 | 5 | 0 | NA |
Capital Surplus | 666 | 305 | 330 | 158 | NA |
Retained Earnings | -288 | -173 | -104 | -51 | NA |
Other Equity | 30 | 21 | 12 | 2 | NA |
Treasury Stock | 0 | 0 | 0 | 0 | NA |
Total Shareholder's Equity | 416 | 157 | 242 | 109 | NA |
Total Liabilities & Shareholder's Equity | 432 | 177 | 251 | 115 | NA |
Total Common Equity | 416 | 157 | 242 | 109 | 0 |
Shares Outstanding | NA | 31.80 | 31.80 | NA | NA |
Book Value Per Share | 0.00 | 4.95 | 7.63 | 0.00 | 0.00 |
Fiscal Year End for Pharvaris NV falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 370 | 400 | 423 | 172 | 195 |
Receivables | 2 | 1 | 1 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 6 | 8 | 6 | 11 | 10 |
Total Current Assets | 378 | 409 | 431 | 183 | 206 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 379 | 410 | 432 | 184 | 207 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 6 | 3 | 5 | 6 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 17 | 13 | 12 | 13 | 11 |
Income Taxes Payable | 0 | 1 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 21 | 20 | 16 | 18 | 17 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 21 | 20 | 16 | 18 | 17 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 7 | 7 | 7 | 5 | 5 |
Capital Surplus | 667 | 670 | 666 | 386 | 385 |
Retained Earnings | -350 | -319 | -288 | -253 | -228 |
Other Equity | 34 | 32 | 30 | 29 | 26 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 358 | 390 | 416 | 167 | 189 |
Total Liabilities & Shareholder's Equity | 379 | 410 | 432 | 184 | 207 |
Total Common Equity | 358 | 390 | 416 | 167 | 189 |
Shares Outstanding | NA | NA | NA | NA | NA |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |